<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2021.08.01.21261458</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Infectious Diseases (except HIV/AIDS)</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aspergillosis and Mucormycosis in COVID-19 Patients; a Systematic Review and Meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Afzal</surname><given-names>Saira</given-names><prefix>Prof.</prefix></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nasir</surname><given-names>Mehreen</given-names><prefix>Dr.</prefix></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>King Edward Medical University</institution>, 03344338525, <email>sairamust@gmail.com</email></aff>
<aff id="a2"><label>2</label><institution>King Edward Medical University</institution>, 03324716020, <email>fabia.nasir@gmail.com</email></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Corresponding author; email: <email>fabia.nasir@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2021</year>
</pub-date>
<elocation-id>2021.08.01.21261458</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>8</month>
<year>2021</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>8</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>8</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2021</copyright-year>
<license><license-p>The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</license-p></license>
</permissions>
<self-uri xlink:href="21261458.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Fungal infections have increased in number since the onset of this lethal pandemic. The aim of this study is to assess risk factors and case fatality in COVID-19 cases with aspergillosis or mucormycosis. Systematic review and meta-analysis was done according to PRISMA guidelines. Data bases used were Google scholar, Pakmedinet, PUBMED and MEDLINE. 21 case reports and case series of mucormycosis in COVID-19 patients were identified and mean age was 56.3 years (36 males and 12 females). The most common comorbidity was diabetes and site was Rhino orbital mucormycosis. Case fatality of 48 combined cases was calculated to be 52&#x0025;. 19 articles of aspergillosis were included. Diabetes was the most common comorbidity in cases. The number of male cases were more than females. Incidence of aspergillosis in critically sick COVID-19 patients was calculated to be 9.3&#x0025;. Case fatality was calculated to be 51.2&#x0025;. Screening can be a beneficial tool for decreasing the morbidity and mortality.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>COVID-19</kwd>
<kwd>mucormycosis</kwd>
<kwd>aspergillosis</kwd>
</kwd-group>
<counts>
<page-count count="22"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>No funding was done</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>This is a systematic Review</p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>COVID-19 pandemic started in China and subsequently spread throughout the world at an alarming rate. This disease can involve multiple systems of the body. Recently, researchers and medical care providers have noticed that fungal infections such as aspergillosis and mucormycosis are on an increasing trend among patients already infected with this lethal covid virus. The spores of these fungi are spread everywhere in environment. Normal healthy people continue to breathe in the air without being affected. Getting infected with these fungi is a rare occurrence but patients who are already in an immunocompromised state and suffering from lung diseases due to Covid-19 are more prone to acquiring these devastating pathogens.</p>
<p>Mucormycosis is also known as black fungus. It can affect nasal cavity, sinuses, lungs, gastrointestinal tract and skin. When pathogen enters the blood stream it can cause disseminated mucormycosis. Rhino cerebral is the most common site involved by mucormycosis. This disease does not spread by person to person contact. Treatment is done with anti-fungal drugs and most cases do require surgical recession of site involved.<sup><xref ref-type="bibr" rid="c1">1</xref></sup> Aspergillosis commonly known as mold also affects those who have weakened immune system or any lung disease for example asthmatics or chronic obstructive lung disease. The mortality with this disease is high.<sup><xref ref-type="bibr" rid="c2">2</xref></sup> Aspergillosis and mucormycosis have high prevalence covid-19 positive population. A study done on 184,500,000 people has revealed that 1.78&#x0025; have shown to have serious fungal infections.<sup><xref ref-type="bibr" rid="c3">3</xref></sup> Pakistan has high burden of non-communicable diseases. Surveillance of non-communicable diseases is limited. People are underdiagnosed which causes complications as these diseases are not managed. Fungal infections are opportunistic infections which have high incidence in people with preexisting diseases. Secondly, Pakistan has a high prevalence of tuberculosis which is a risk factor as well.<sup>4-</sup> COVID-19 is a respiratory disease which is a risk factor for opportunistic infection. Influenza, a respiratory illness has also shown to increase the incidence of aspergillosis.<sup><xref ref-type="bibr" rid="c5">5</xref></sup></p>
<p>The rationale of this study is to identify the risk factors and case fatality of aspergillosis or mucormycosis in COVID-19 cases. This study will also identify the incidence of aspergillosis in critically sick persons that will include both ICU patients and mechanically ventilated cases. Knowledge generated from this systematic review will highlight the importance of preventing and early screening in critically sick persons of COVID-19 as this disease has high morbidity and mortality.</p>
</sec>
<sec id="s2">
<title>METHODOLOGY</title>
<p>Systematic review was done according to PRISMA guidelines. My inclusion criteria was original articles and abstracts on aspergillosis or mucormycosis in COVID-19 patients from 1<sup>st</sup> January 2020 to 15<sup>th</sup> June, 2021.</p>
<p>Articles focusing on treatment, management, surgical options, autopsy, postmortem, histopathology findings, molecular detection, genetic studies and laboratory reports were excluded. Articles with language other than English were also excluded.</p>
<p>Data bases used were Google scholar, Pakmedinet, PUBMED and MEDLINE. PRISMA flowchart is shown in the <xref rid="fig1" ref-type="fig">figure 1</xref>. For finding articles Boolean operators of &#x2018;COVID-19 AND (ASPERGILLOSIS OR MUCORMYCOSIS)&#x2019; were used. Date of my search was 15<sup>th</sup> June, 2021.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Identification of studies via databases and registers</title></caption>
<graphic xlink:href="21261458v1_fig1.tif"/>
</fig>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Incidence Rate Ratio of Aspergillosis in critically sick</title></caption>
<graphic xlink:href="21261458v1_fig2.tif"/>
</fig>
<p>2 researchers independently screened the articles of basis of title and abstract. Any discrepancy was solved by discussion. Data of outcome variables was entered in Microsoft Excel. For meta-analysis of mucormycosis in COVID-19 cases 21 case reports and case series were included. Age, gender, site of mucormycosis, preexisting co-morbidities and outcome was noted. For aspergillosis in COVID-19; 19 articles were selected. Case fatality was calculated. Incidence of aspergillosis in COVID-19 patients was calculated. Case reports were excluded for doing meta-analysis of aspergillosis.</p>
</sec>
<sec id="s3">
<title>RESULTS</title>
<p>21 case reports and case series of mucormycosis in COVID-19 patients were identified as shown in <xref ref-type="table" rid="tbl1">table I</xref>. There were total 48 patients in analysis. Mean age was found to be 56.312 years with standard deviation of 15.55 years. There were 36 males and 12 females. The most common comorbidity was diabetes (35 out of 48 cases). Other risk factors included chronic kidney disease, ischemic heart disease, transplant, decompensated liver disease and hypertension. The most common site was Rhino orbital mucormycosis. However cutaneous, gastrointestinal and pulmonary mucormycosis were also reported. 25 cases died and 23 were discharged. Chi-square test did not show significant difference in outcome between males and females (p-value 0.133). Combined case fatality of 48 cases was calculated to be 52&#x0025;.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table I:</label>
<caption><title>Case Reports and Case Series of Mucormycosis</title></caption>
<graphic xlink:href="21261458v1_tbl1.tif"/>
<graphic xlink:href="21261458v1_tbl1a.tif"/>
<graphic xlink:href="21261458v1_tbl1b.tif"/>
<graphic xlink:href="21261458v1_tbl1c.tif"/>
<graphic xlink:href="21261458v1_tbl1d.tif"/>
<graphic xlink:href="21261458v1_tbl1e.tif"/>
</table-wrap>
<p>19 articles meeting the inclusion criteria were included. Diabetes was the most common comorbidity in cases. Other risk factors include hypertension, steroid use, hypertension, heart disease, chronic obstructive pulmonary disease, malignancies and chronic kidney disease. The number of male cases were more than females.<sup><xref ref-type="bibr" rid="c36">36</xref>,<xref ref-type="bibr" rid="c40">40</xref></sup> Combined incidence was 9.3&#x0025;. Case fatality was calculated to be 51.2&#x0025; as shown in <xref ref-type="table" rid="tbl2">Table II</xref>. Incidence of aspergillosis in critically sick COVID-19 patients was calculated by including 9 studies as shown in <xref ref-type="table" rid="tbl3">Table III</xref>. Forest plot shows the incidence of aspergillosis in critically sick COVID-19 patients using 95&#x0025; confidence interval.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table II:</label>
<caption><title>Number of cases who died due to aspergillosis in COVID-19</title></caption>
<graphic xlink:href="21261458v1_tbl2.tif"/>
</table-wrap>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table III:</label>
<caption><title>Incidence of aspergillosis in critically sick patients of COVID-19</title></caption>
<graphic xlink:href="21261458v1_tbl3.tif"/>
</table-wrap>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>The aim of this study was to assess the risk factors and case fatality of aspergillosis and mucormycosis in COVID-19 patients. Incidence of aspergillosis in critically sick patients that included both intensive care unit patients and mechanically ventilated patients of COVID-19 has also been calculated. This study highlighted the importance of prevention and early screening of fungal infections in severe cases of COVID-19 as this lethal disease has high morbidity and mortality. Repeated surgical interventions are required to remove infected tissue which causes disfigurement and mental trauma.</p>
<p>Mean age of cases with mucormycosis was 56 years. This result is similar to other studies.<sup><xref ref-type="bibr" rid="c45">45</xref></sup> The number of males are more than females. This finding is consistent with previous study.<sup><xref ref-type="bibr" rid="c46">46</xref></sup> A retrospective study in Mexico has shown more male patients of mucormycosis. There are more males in this study as severe COVID-19 and mucormycosis both are generally more common in males.<sup><xref ref-type="bibr" rid="c47">47</xref></sup></p>
<p>Diabetes was the most common risk factor found in other systematic reviews of mucormycosis.<sup>48-95</sup> Diabetes is an immunocompromised state and its prevalence is high across the globe. Rhino orbital mucormycosis was the most common site in cases.<sup><xref ref-type="bibr" rid="c50">50</xref></sup> The combined case fatality in this study was found to be 52&#x0025;. The mortality of pulmonary mucormycosis is slightly higher. A study done has demonstrated mortality of 57&#x0025;. Another systematic review on mucormycosis has shown 67&#x0025; survival with antifungal medications and surgery.<sup><xref ref-type="bibr" rid="c51">51</xref></sup> This study has reported higher mortality (52&#x0025;). This may be due to the fact that cases of mucormycosis has COVID-19 infection as well which has resulted in higher case fatality.</p>
<p>Aspergillosis has higher incidence in critically sick COVID-19 patients. That demands for early screening. The combined incidence was found to be 9.3&#x0025; with range of 1.88&#x0025; to 25&#x0025;. In another systematic review the incidence was found to be 13.5&#x0025;.<sup><xref ref-type="bibr" rid="c51">51</xref></sup> This may be due to the fact that in this study both mechanically ventilated and not mechanically ventilated Intensive Care Unit (ICU) patients were included. The average case fatality was found to be 51.2&#x0025;. Another systematic review has calculated the case fatality of aspergillosis to be 58&#x0025;.<sup><xref ref-type="bibr" rid="c52">52</xref></sup> A systematic review of pulmonary aspergillosis in COVID-19 cases; case fatality was found to be 48.4&#x0025;.<sup><xref ref-type="bibr" rid="c51">51</xref></sup> The risk factors of aspergillosis were diabetes, hypertension, steroid use, hypertension, heart disease, chronic obstructive pulmonary disease, malignancies and chronic kidney disease.</p>
<p>The strengths of this study are that it is a systematic review and meta-analysis. Thorough data search has been done. It has covered 2 lethal fungal infections which have shown increased prevalence since covid pandemic. However more prospective studies should be done to understand more about pathogenesis of this disease. The most common risk factor was diabetes. Health education and lifestyle modifications should be promoted to halt the rise in diabetes. Early screening and good glycemic control can also be helpful for those who have already developed diabetes to prevent complications.</p>
</sec>
<sec id="s5">
<title>Conclusion</title>
<p>Case fatality from aspergillosis and mucormycosis in Covid-19 cases is quite high. Incidence of aspergillosis in critically sick COVID cases is around 9.2&#x0025;. Screening can be a beneficial tool for decreasing the morbidity and mortality.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>Data was collected from articles case reports series and prospective studies.</p>
</sec>
<sec id="s6">
<title>Conflict Of Interest</title>
<p>None</p>
</sec>
<sec id="s7">
<title>DISCLOSURE</title>
<p>None</p>
</sec>
<sec id="s8">
<title>FUNDING</title>
<p>None</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="website"><collab>Mucormycosis</collab>. <source>Centers for Disease Control and Prevention</source>. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/fungal/diseases/mucormycosis/index.html">https://www.cdc.gov/fungal/diseases/mucormycosis/index.html</ext-link>. (Accessed <date-in-citation content-type="access-date">22/06/2021</date-in-citation>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="website"><collab>Aspergillosis</collab>. <source>Centers for Disease Control and Prevention</source>. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/fungal/diseases/aspergillosis/index.html">https://www.cdc.gov/fungal/diseases/aspergillosis/index.html</ext-link>. (Accessed <date-in-citation content-type="access-date">22/06/2021</date-in-citation>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Jabeen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Farooqi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mirza</surname> <given-names>S</given-names></string-name>, <string-name><surname>Denning</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zafar</surname> <given-names>A.</given-names></string-name> <article-title>Serious fungal infections in Pakistan</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis</source>. <year>2017</year>;<volume>36</volume>(<issue>6</issue>):<fpage>949</fpage>&#x2013;<lpage>56</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="website"><collab>National Institute of Health Islamabad</collab>. <source>National TB Control Program - National Institute of Health Islamabad</source>. <ext-link ext-link-type="uri" xlink:href="https://www.nih.org.pk/national-tb-control-program">https://www.nih.org.pk/national-tb-control-program</ext-link>. (Accessed <date-in-citation content-type="access-date">22/06/2021</date-in-citation>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Waldeck</surname> <given-names>F</given-names></string-name>, <string-name><surname>Boroli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Suh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wendel Garcia</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Flury</surname> <given-names>D</given-names></string-name>, <string-name><surname>Notter</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Influenza-associated aspergillosis in critically-ill patients&#x2014;a retrospective bicentric cohort study</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis</source>. <year>2020</year>;<volume>39</volume>:<fpage>1915</fpage>&#x2013;<lpage>23</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Fouad</surname> <given-names>YA</given-names></string-name>, <string-name><surname>Abdelaziz</surname> <given-names>TT</given-names></string-name>, <string-name><surname>Askoura</surname> <given-names>A</given-names></string-name>, <string-name><surname>Saleh</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Mahmoud</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Ashour</surname> <given-names>MM</given-names></string-name>. <article-title>Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic</article-title>. <source>Front. Med</source>. <year>2021</year>;<volume>8</volume>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="website"><collab>Clinical Characteristics And Outcomes of 16 Cases With COVID19 and Mucormycosis: Experience From A Tertiary Care Center In India and Review of Literature</collab>. Available from: <ext-link ext-link-type="uri" xlink:href="https://assets.researchsquare.com/files/rs-533347/v1/78a6c40d-83f5-4c53-a31b-ef3c8a06a4bb.pdf">https://assets.researchsquare.com/files/rs-533347/v1/78a6c40d-83f5-4c53-a31b-ef3c8a06a4bb.pdf</ext-link> [cited 15 July 2021].</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="website"><collab>COVID-19 associated rhinosinusitis mucormycosis due to Rhizopus arrhizus: A rare but potentially fatal infection occurring after treatment with corticosteroids</collab>. Available from: <ext-link ext-link-type="uri" xlink:href="https://assets.researchsquare.com/files/rs-398594/v1/5e4c735f-f595-4a7e-a8f9-b76a3210c58c.pdf">https://assets.researchsquare.com/files/rs-398594/v1/5e4c735f-f595-4a7e-a8f9-b76a3210c58c.pdf</ext-link> [cited 15 July 2021].</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Bayram</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ozsayg&#x0131;l&#x0131;</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sav</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tekin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gundogan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pangal</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations</article-title>. <source>Jpn. J. Ophthalmol</source> <year>2021</year>;<volume>31</volume>:<fpage>1</fpage>&#x2013;<lpage>1</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Shah</surname> <given-names>D</given-names></string-name>, <string-name><surname>Talwar</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Acharya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dubey</surname> <given-names>A.</given-names></string-name> <article-title>Mucormycosis as a complication of LONG COVID: A case series</article-title>. <source>J. Med. Sci</source>. <year>2021</year>;<volume>25</volume>(<issue>112</issue>):<fpage>1331</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Waizel-Haiat</surname> <given-names>S</given-names></string-name>, <string-name><surname>Guerrero-Paz</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Sanchez-Hurtado</surname> <given-names>L</given-names></string-name>, <string-name><surname>Calleja-Alarcon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Romero-Gutierrez</surname> <given-names>L.</given-names></string-name> <article-title>A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19</article-title>. <source>Cureus</source> <year>2021</year>;<volume>13</volume>(<issue>2</issue>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Alekseyev</surname> <given-names>K</given-names></string-name>, <string-name><surname>Didenko</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chaudhry</surname> <given-names>B.</given-names></string-name> <article-title>Rhinocerebral mucormycosis and COVID-19 pneumonia</article-title>. <source>J. Med. Case Rep</source>. <year>2021</year>;<volume>12</volume>(<issue>3</issue>):<fpage>85</fpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Khatri</surname> <given-names>A</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Berlinrut</surname> <given-names>I</given-names></string-name>, <string-name><surname>Wallach</surname> <given-names>F.</given-names></string-name> <article-title>Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient&#x2013;case report and review of literature</article-title>. <source>Med. Mycol</source>. <year>2021</year>;<volume>31</volume>(<issue>2</issue>):<fpage>101125</fpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Maini</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tomar</surname> <given-names>G</given-names></string-name>, <string-name><surname>Khanna</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kini</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mehta</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bhagyasree</surname> <given-names>V.</given-names></string-name> <article-title>Sino-orbital mucormycosis in a COVID-19 patient: A case report</article-title>. <source>Int. J. Surg. Case Rep</source>. <year>2021</year>;<volume>82</volume>:<fpage>105957</fpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>do Monte Junior</surname> <given-names>ES</given-names></string-name>, <string-name><surname>Dos Santos</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Ribeiro</surname> <given-names>IB</given-names></string-name>, <string-name><surname>de Oliveira Luz</surname> <given-names>G</given-names></string-name>, <string-name><surname>Baba</surname> <given-names>ER</given-names></string-name>, <string-name><surname>Hirsch</surname> <given-names>BS</given-names></string-name>, <etal>et al.</etal> <article-title>Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report</article-title>. <source>Clin. Endosc</source>. <year>2020</year>;<volume>53</volume>(<issue>6</issue>):<fpage>746</fpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Mehta</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pandey</surname> <given-names>A.</given-names></string-name> <article-title>Rhino-orbital mucormycosis associated with COVID-19</article-title>. <source>Cureus</source> <year>2020</year>;<volume>12</volume>(<issue>9</issue>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Khan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gutierrez</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Martinez</surname> <given-names>DV</given-names></string-name>, <string-name><surname>Proud</surname> <given-names>KC</given-names></string-name>. <article-title>A case report of COVID-19 associated pulmonary mucormycosis</article-title>. <source>Arch. Clin. Cases</source>. <year>2021</year>;<volume>7</volume>(<issue>3</issue>):<fpage>2020</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Revannavar</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Supriya</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Samaga</surname> <given-names>L</given-names></string-name>, <string-name><surname>Vineeth</surname> <given-names>VK</given-names></string-name>. <article-title>COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?</article-title>. <source>BMJ Case Rep</source>. <year>2021</year>;<volume>14</volume>(<issue>4</issue>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Farid</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Hashim</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Hasrat</surname> <given-names>NH</given-names></string-name>. <article-title>Rhinocerebral Mucormycosis as a COVID-19-Related Complication: A Case Report from Basra City, Southern Iraq</article-title>. <source>Int. J. Glob. Sci. Res</source>. <year>2021</year>;<volume>6</volume>(<issue>5</issue>):<fpage>1369</fpage>&#x2013;<lpage>74</lpage>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Meshram</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Kute</surname> <given-names>VB</given-names></string-name>, <string-name><surname>Chauhan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Desai</surname> <given-names>S.</given-names></string-name> <article-title>Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up</article-title>. <source>Transpl Infect Dis</source>. <year>2021</year>;<volume>3</volume>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Mekonnen</surname> <given-names>ZK</given-names></string-name>, <string-name><surname>Ashraf</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Jankowski</surname> <given-names>T</given-names></string-name>, <string-name><surname>Grob</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Vagefi</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Kersten</surname> <given-names>RC</given-names></string-name>, <etal>et al.</etal> <article-title>Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome</article-title>. <source>Ophthalmic Plast Reconstr Surg</source>. <year>2021</year>;<volume>37</volume>(<issue>2</issue>).</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Ghazarian</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Cendrowski</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Persichino</surname> <given-names>JG</given-names></string-name>. <article-title>Pulmonary aspergillosis and mucormycosis in a patient with COVID-19</article-title>. <source>Med. Mycol. Case Rep</source>. <year>2021</year>;<volume>32</volume>:<fpage>64</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Chowdhary</surname> <given-names>S.</given-names></string-name> <article-title>The Face of the COVID-19 Pandemic: Invasive Rhino-Orbital Mucormycosis</article-title>. <source>Clin Surg J</source>. <year>2021</year>;<volume>4</volume>(<issue>S7</issue>):<fpage>14</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Saldanha</surname> <given-names>M</given-names></string-name>, <string-name><surname>Reddy</surname> <given-names>R</given-names></string-name>, <string-name><surname>Vincent</surname> <given-names>MJ</given-names></string-name>. <article-title>Paranasal mucormycosis in COVID-19 patient. Indian J. Otolaryngol</article-title>. <source>Head Neck Surg</source> <year>2021</year>;<volume>22</volume>:<fpage>1</fpage>&#x2013;<lpage>4</lpage>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Pasero</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sanna</surname> <given-names>S</given-names></string-name>, <string-name><surname>Liperi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Piredda</surname> <given-names>D</given-names></string-name>, <string-name><surname>Branca</surname> <given-names>GP</given-names></string-name>, <string-name><surname>Casadio</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis</article-title>. <source>Infection</source> <year>2020</year> :<fpage>1</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Garg</surname> <given-names>D</given-names></string-name>, <string-name><surname>Muthu</surname> <given-names>V</given-names></string-name>, <string-name><surname>Sehgal</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Ramachandran</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kaur</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bhalla</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature</article-title>. <source>Mycopathologia</source> <year>2021</year>;<volume>5</volume>:<fpage>1</fpage>&#x2013;<lpage>0</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Delli&#x00E8;re</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dudoignon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Fodil</surname> <given-names>S</given-names></string-name>, <string-name><surname>Voicu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Collet</surname> <given-names>M</given-names></string-name>, <string-name><surname>Oillic</surname> <given-names>PA</given-names></string-name>, <etal>et al.</etal> <article-title>Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort</article-title>. <source>Clin. Microbiol. Infect</source>. <year>2021</year>;<volume>27</volume>(<issue>5</issue>):<fpage>790</fpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Versyck</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zarrougui</surname> <given-names>W</given-names></string-name>, <string-name><surname>Lambiotte</surname> <given-names>F</given-names></string-name>, <string-name><surname>Elbeki</surname> <given-names>N</given-names></string-name>, <string-name><surname>Saint-Leger</surname> <given-names>P.</given-names></string-name> <article-title>Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort</article-title>. <source>Med. Mycol. J</source>. <year>2021</year>;<volume>31</volume>(<issue>2</issue>):<fpage>101122</fpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Gouzien</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cocherie</surname> <given-names>T</given-names></string-name>, <string-name><surname>Eloy</surname> <given-names>O</given-names></string-name>, <string-name><surname>Legriel</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bedos</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Simon</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Invasive Aspergillosis associated with Covid-19: A word of caution</article-title>. <source>Infectious Diseases Now</source> <year>2021</year>;<volume>51</volume>(<issue>4</issue>):<fpage>383</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="website"><collab>Bacterial and Fungal Co-Infections in Patients with COVID-19 Related Pneumonia: A Retrospective Cohort Study</collab>. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.researchsquare.com/article/rs-576997/v1">https://www.researchsquare.com/article/rs-576997/v1</ext-link> [cited 15 July 2021].</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Lahmer</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kriescher</surname> <given-names>S</given-names></string-name>, <string-name><surname>Herner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rothe</surname> <given-names>K</given-names></string-name>, <string-name><surname>Spinner</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Schneider</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study</article-title>. <source>Plos one</source>. <year>2021</year>;<volume>16</volume>(<issue>3</issue>).</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Pintado</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Camiro-Z&#x00FA;&#x00F1;iga</surname> <given-names>A</given-names></string-name>, <string-name><surname>Soto</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Cuenca</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mercado</surname> <given-names>M</given-names></string-name>, <string-name><surname>Crabtree-Ramirez</surname> <given-names>B.</given-names></string-name> <article-title>COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City</article-title>. <source>Med Mycol</source>. <year>2021</year>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>van Arkel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rijpstra</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Belderbos</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>van Wijngaarden</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Verweij</surname>, <given-names>P. E.</given-names></string-name>, <string-name><surname>Bentvelsen</surname> <given-names>R. G.</given-names></string-name> <article-title>COVID-19-associated Pulmonary Aspergillosis</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2020</year>;<volume>202</volume>(<issue>1</issue>):<fpage>132</fpage>&#x2013;<lpage>135</lpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Bartoletti</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pascale</surname> <given-names>R</given-names></string-name>, <string-name><surname>Cricca</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rinaldi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maccaro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bussini</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study</article-title>. <source>Clin Infect Dis</source>. <year>2020</year>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Machado</surname> <given-names>M</given-names></string-name>, <string-name><surname>Valerio</surname> <given-names>M</given-names></string-name>, <string-name><surname>&#x00C0;lvarez-Ur&#x00ED;a</surname> <given-names>A</given-names></string-name>, <string-name><surname>Olmedo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Veintimilla</surname> <given-names>C</given-names></string-name>, <string-name><surname>Padilla</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity</article-title>. <source>Mycoses</source> <year>2021</year>;<volume>64</volume>(<issue>2</issue>):<fpage>132</fpage>&#x2013;<lpage>43</lpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Nasir</surname> <given-names>N</given-names></string-name>, <string-name><surname>Farooqi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mahmood</surname> <given-names>SF</given-names></string-name>, <string-name><surname>Jabeen</surname> <given-names>K.</given-names></string-name> <article-title>COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan</article-title>. <source>Mycoses</source> <year>2020</year>;<volume>63</volume>(<issue>8</issue>):<fpage>766</fpage>&#x2013;<lpage>70</lpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Lai</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>WL</given-names></string-name>. <article-title>COVID-19 associated with pulmonary aspergillosis: A literature review</article-title>. <source>J Microbiol Immunol Infect</source>. <year>2021</year>;<volume>54</volume>(<issue>1</issue>):<fpage>46</fpage>&#x2013;<lpage>53</lpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Kariyawasam</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Dingle</surname> <given-names>TC</given-names></string-name>, <string-name><surname>Kula</surname> <given-names>BE</given-names></string-name>, <string-name><surname>Sligl</surname> <given-names>WI</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>IS</given-names></string-name>. <article-title>COVID-19 Associated Pulmonary Aspergillosis: Systematic Review and Patient-Level Meta-analysis</article-title>. <source>medRxiv</source>. <year>2021</year>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Chong</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Neu</surname> <given-names>KP</given-names></string-name>. <article-title>The incidence, diagnosis, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review</article-title>. <source>J Hosp Infect</source>. <year>2021</year>;<volume>113</volume>: <fpage>115</fpage>&#x2013;<lpage>129</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Pintado</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Camiro-Z&#x00FA;&#x00F1;iga</surname> <given-names>A</given-names></string-name>, <string-name><surname>Soto</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Cuenca</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mercado</surname> <given-names>M</given-names></string-name>, <string-name><surname>Crabtree-Ramirez</surname> <given-names>B.</given-names></string-name> <article-title>COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City</article-title>. <source>Med mycol</source>. <year>2021</year>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Apostolopoulou</surname> <given-names>A</given-names></string-name>, <string-name><surname>Esquer Garrigos</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Vijayvargiya</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lerner</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Farmakiotis</surname> <given-names>D.</given-names></string-name> <article-title>Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature</article-title>. <source>Diagnostics</source> <year>2020</year>;<volume>10</volume>(<issue>10</issue>):<fpage>807</fpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Salmanton-Garcia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sprute</surname> <given-names>R</given-names></string-name>, <string-name><surname>Stemler</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bartoletti</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dupont</surname> <given-names>D</given-names></string-name>, <string-name><surname>Valerio</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>COVID-19&#x2013;associated pulmonary aspergillosis, March&#x2013;August 2020</article-title>. <source>Emerg. Infect. Dis</source>. <year>2021</year>;<volume>27</volume>(<issue>4</issue>):<fpage>1077</fpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Abdalla</surname> <given-names>S</given-names></string-name>, <string-name><surname>Almaslamani</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Hashim</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Ibrahim</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Omrani</surname> <given-names>AS</given-names></string-name>. <article-title>Fatal coronavirus disease 2019-associated pulmonary aspergillosis; a report of two cases and review of the literature</article-title>. <source>IDCases</source>. <year>2020</year>;<volume>22</volume>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Alobaid</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yousuf</surname> <given-names>B</given-names></string-name>, <string-name><surname>Al-Qattan</surname> <given-names>E</given-names></string-name>, <string-name><surname>Muqeem</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Al-Subaie</surname> <given-names>N.</given-names></string-name> <article-title>Pulmonary aspergillosis in two COVID-19 patients from Kuwait</article-title>. <source>Access Microbiol</source> <year>2021</year>;<volume>3</volume>(<issue>3</issue>):<fpage>000201</fpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Ravani</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Leuva</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Modi</surname> <given-names>PH</given-names></string-name>, <string-name><surname>Amin</surname> <given-names>KD</given-names></string-name>. <article-title>Rise of the phoenix: Mucormycosis in COVID-19 times</article-title>. <source>Indian J. Ophthalmol</source>. <year>2021</year>;<volume>69</volume>(<issue>6</issue>):<fpage>1563</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Pakdel</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ahmadikia</surname> <given-names>K</given-names></string-name>, <string-name><surname>Salehi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tabari</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jafari</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mehrparvar</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicenter study from Iran</article-title>. <source>Mycoses</source> <year>2021</year>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Bonifaz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tirado-S&#x00E1;nchez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez-Medel</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Araiza</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kassack</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>del Angel-Arenas</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mois&#x00E9;s-Hern&#x00E1;ndez</surname> <given-names>JF</given-names></string-name>, <etal>et al.</etal> <article-title>Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases</article-title>. <source>Mycoses</source> <year>2021</year>;<volume>64</volume>(<issue>4</issue>):<fpage>372</fpage>&#x2013;<lpage>80</lpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Jeong</surname> <given-names>W</given-names></string-name>, <string-name><surname>Keighley</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wolfe</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>WL</given-names></string-name>, <string-name><surname>Slavin</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>DC</given-names></string-name>, <etal>et al.</etal> <article-title>The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports</article-title>. <source>Clin. Microbiol. Infect</source>. <year>2019</year>;<volume>25</volume>(<issue>1</issue>):<fpage>26</fpage>&#x2013;<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Vaezi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Moazeni</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rahimi</surname> <given-names>MT</given-names></string-name>, <string-name><surname>de Hoog</surname> <given-names>S</given-names></string-name>, <string-name><surname>Badali</surname> <given-names>H.</given-names></string-name> <article-title>Mucormycosis in Iran: a systematic review</article-title>. <source>Mycoses</source> <year>2016</year>;<volume>59</volume>(<issue>7</issue>):<fpage>402</fpage>&#x2013;<lpage>15</lpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Muthu</surname> <given-names>V</given-names></string-name>, <string-name><surname>Agarwal</surname> <given-names>R</given-names></string-name>, <string-name><surname>Dhooria</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sehgal</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Prasad</surname> <given-names>KT</given-names></string-name>, <string-name><surname>Aggarwal</surname> <given-names>AN</given-names></string-name>, <etal>et al.</etal> <article-title>Has the mortality from pulmonary mucormycosis changed over time? a systematic review and meta-analysis</article-title>. <source>Clin. Microbiol. Infect</source>. <year>2021</year>;<volume>27</volume>(<issue>4</issue>):<fpage>538</fpage>&#x2013;<lpage>549</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Chong</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Neu</surname> <given-names>KP</given-names></string-name>. <article-title>The incidence, diagnosis, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review</article-title>. <source>J Hosp Infect</source>. <year>2021</year>;<volume>113</volume>:<fpage>115</fpage>&#x2013;<lpage>129</lpage>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Schranz</surname> <given-names>J</given-names></string-name>, <string-name><surname>Teutsch</surname> <given-names>SM</given-names></string-name>. <article-title>Aspergillosis case-fatality rate: systematic review of the literature</article-title>. <source>Clin. Infect. Dis</source>. <year>2001</year>;<volume>32</volume>(<issue>3</issue>):<fpage>358</fpage>&#x2013;<lpage>66</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>